Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First fully-automated bladder cancer test launched:

This article was originally published in Clinica

Executive Summary

Diagnostic Products is launching a fully automated version of Matritech's NMP22 urine test for bladder cancer, which is claimed to be the world's first such test. The automated version, which is designed to be performed on the firm's IMMULITE fully automated analyser, is less labour-intensive and could provide urologists with patient results in around one day, said the Los Angeles, California firm. The test will be available initially outside the US, excluding Japan, and in the US following FDA PMA approval.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065963

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel